Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHMI in Semi-Immune Adults
NCT02739763Phase 1Unknown
- Sponsor
- University of Oxford
- Start
- May 2016
- Primary completion
- Jan 2020
- Modality
- Live Biotherapeutic Products, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of PfSPZ Challenge in malaria, sponsored by University of Oxford. Primary endpoint: Infectivity of PfSPZ (malaria infection). Status: unknown.
02
Drugs
PfSPZ Challenge
03
Conditions
malaria
Beyond the preview
Go deeper on NCT02739763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02739763.